Wells et al. demonstrated that combined administration of pentagastrin and calcium gluconate showed the most effective and reliable results for calcitonin secretion from MTC tumors [12] . Since then, this protocol has been widely accepted for screening, early diagnosis and evaluation of the postoperative biochemical cure of MTC patients; however, recently, this test has been halted because gastrin is no longer available for clinical use, not only in Japan but also in the United States. Thus, a provocative test using only calcium gluconate is currently performed. In addition, the assay system for serum calcitonin has changed during the past 25 years with changes in standard values, sensitivity and specificity; however, standard values for the calcium stimulation test using the current calcitonin assay system have not been reported. We therefore conducted stimulation tests for 20 patients before and after total thyroidectomy for thyroid diseases other than MTC. the peak to basal value (P/B ratio) ranged from 0.53-to 5.23-fold. The ratio was greater than 3 in 3 patients (Fig. 2 ). Peak calcitonin levels exceeded 100 pg/mL after stimulation in two patients (110 pg/mL and 160 pg/mL, respectively (Fig. 3) . After total thyroidectomy, their basal calcitonin level slightly decreased to 21 ± 4.6 pg/mL, not significantly different from the preoperative basal value; however, calcitonin levels did not show a significant response to calcium loading after total thyroidectomy. The calcitonin values 3 and 5 minutes after calcium injection were 22 ± 4.7 pg/ mL(P=0.62) and 21 ± 4.6 pg/mL (P=0.91), respectively ( Fig. 1-b) . Their P/B ratio ranged from 0.86-to 1.73-fold, and none exceeded 2-fold. Fig. 3 shows individual changes in basal and peaked calcitonin levels preand postoperatively in 20 patients. Before surgery, 6 patients (30%) had a more than 2-fold increase and 3 (15%) a more than 3-fold increase of the calcitonin
Patients and Methods
Twenty patients undergoing a total thyroidectomy for thyroid diseases other than MTC in our hospital were enrolled in this study. They consisted of 3 males and 17 females, ranging from 37 to 62 years of age, with a mean of 48.8 years. Total thyroidectomy was performed for papillary carcinoma, multinodular goiter, suspicious follicular carcinoma and Graves' disease in 16, 2, 1 and 1 patient, respectively. For each patient, 8.5% calcium gluconate (0.25 mL/kg) was intravenously injected for 1 minute, and blood samples for calcitonin measurement were drawn before and 3 and 5 minutes after the injection. The test was performed before and 3 days after surgery. Serum calcitonin was measured by a laboratory (SRL Co., Japan) using the solid two-site immunoradiometric assay (Mitubishi Chemical Co., Japan). According to the manufacturer, the normal ranges of basal serum calcitonin are 17.1 pg/mL to 58.7 pg/mL for female and 16.6 pg/mL to 95.4 pg/mL for male subjects. The present study was approved by the ethics committee of our hospital and written informed consent was obtained from each participating patient.
results
Basal calcitonin levels before total thyroidectomy in 20 patients were 24.1 ± 5.6 pg/mL (mean ± SD). Following calcium loading, serum calcitonin increased with variable degrees in the majority of patients. Their calcitonin levels 3 and 5 minutes after calcium injection were 45.3 ± 35.5 pg/mL (P<0.01) and 41.2 ± 26.8 pg/mL (P<0.01), respectively ( Fig. 1-a) . The ratio of patients before(a) and after(b) total thyroidectomy.
Fig. 2
The ratio of the peak value to the basal value (P/B ratio) before and after total thyroidectomy in 20 patients.
the diagnosis of small MTC or C-cell hyperplasia in the setting of family screening or to evaluate the extent of surgical treatment. In order to improve sensitivity, a combined intravenous calcium gluconate and pentagastrin stimulation test was widely used; however, gastrin has become unavailable for clinical use. Thus, currently, a provocative test using only calcium gluconate is performed. The assay system for calcitonin has also changed. As a consequence, reliable standard values for this test are unavailable, which is why we conducted calcium stimulation tests in 20 patients before and after total thyroidectomy for thyroid diseases other than MTC.
In previous studies, when basal and stimulated serum calcitonin levels were within normal limits and the peak stimulated levels were less than three-fold the basal levels, patients were regarded as normal or biochemically cured [13] [14] [15] [16] [17] ; however, in our series of patients without MTC, 2 patients (10%) showed stimulated calcitonin levels exceeding the upper normal range and 3 patients (15%) showed a P/B ratio three-fold greater after calcium injection. Pathological examination of thyroidectomy specimens revealed MTC in none of these patients. In our series of so-called prophylactic total thyroidectomy for eight family members of hereditary MTC without detectable tumors by ultrasonography, the lowest peak calcitonin level and the minimum P/B ratio of preoperative calcium stimulation tests with or without pentagastrin in patients was 92 pg/mL and 2.7 (Table 1 ). This finding indicates that the calcium infusion test is not always reliable for the preoperative diagnosis of MTC. Such a discrepancy has also been reported by Gibelin et al. , who demonstrated that not only basal but also pentagastrin-stimulated calcitonin levels overlapped among patients with medullevel after calcium injection, while none of the present patients after total thyroidectomy showed an increase of the calcitonin level of more than 2-fold, even after stimulation (Fig. 2) . Surgically resected thyroid glands were pathologically examined and none was found to contain medullary carcinoma foci.
discussion
Although serum calcitonin is very useful for the diagnosis of MTC, it may not be sensitive enough for However, after total thyroidectomy, none of the 20 patients without MTC showed an increase of the calcitonin level more than 2-fold the basal level following the calcium stimulation test, indicating that responses greater than 2-fold after MTC surgery might be abnormal, indicating the presence of residual tumor.
In summary, some subjects without MTC may show a response to the calcium stimulation test up to 5.24-fold the basal level, suggesting the requirement of judicious judgment for the early diagnosis of MTC in family members; however, after total thyroidectomy, none of the subjects showed an increase more than 2-fold the basal level, suggesting that responses greater than 2-fold after MTC surgery might be abnormal, indicating the presence of residual tumor. lary carcinoma, micromedullary carcinoma and those without medullary carcinoma [18] . MTC can also be diagnosed by fine needle aspiration biopsy (FNAB), although its sensitivity was reported to be 63% [5] . We previously showed that calcitonin measurement in the wash-out of needles used for FNAB is another useful approach, especially to diagnose small MTC [19] . These approaches should also be adopted for the diagnosis of MTC together with measurements of basal and calcium-stimulated calcitonin levels. In order to screen for hereditary MTC, ret mutation analysis is mandatory rather than biochemical tests, since gene analysis is much more reliable [17] . The calcium infusion test might give false positive results as has been reported and as the present study suggests.
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